Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.16M | 12.88M | 11.37M | 9.43M | 14.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.16M | 12.88M | 11.37M | 9.43M | 14.22M |
| Cost of Revenue | 7.17M | 4.58M | 4.29M | 3.77M | 5.26M |
| Gross Profit | 12.00M | 8.30M | 7.08M | 5.67M | 8.96M |
| SG&A Expenses | 11.04M | 8.33M | 8.83M | 7.91M | 10.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.15M | 13.71M | 13.95M | 12.48M | 17.27M |
| Operating Income | 11.00K | -832.00K | -2.57M | -3.05M | -3.05M |
| Income Before Tax | -1.15M | -1.88M | -3.69M | -4.12M | -4.57M |
| Income Tax Expenses | 94.00K | 78.00K | 49.00K | 49.00K | 89.00K |
| Earnings from Continuing Operations | -1.24M | -1.96M | -3.74M | -4.17M | -4.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -59.00K | -29.00K | -40.00K | 22.00K | 31.00K |
| Net Income | -1.30M | -1.98M | -3.78M | -4.15M | -4.63M |
| EBIT | 11.00K | -832.00K | -2.57M | -3.05M | -3.05M |
| EBITDA | 232.00K | -668.00K | -2.44M | -2.91M | -2.91M |
| EPS Basic | -0.03 | -0.05 | -0.09 | -0.10 | -0.12 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.06 | -0.06 | -0.07 |
| EPS Diluted | -0.03 | -0.05 | -0.09 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.06 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 42.16M | 40.75M | 40.73M | 40.73M | 38.22M |
| Average Diluted Shares Outstanding | 42.16M | 40.75M | 40.73M | 40.73M | 38.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |